PT  - JOURNAL ARTICLE
AU  - Bilinski, Alyssa
AU  - Ciaranello, Andrea
AU  - Fitzpatrick, Meagan C.
AU  - Giardina, John
AU  - Shah, Maunank
AU  - Salomon, Joshua A.
AU  - Kendall, Emily A.
TI  - SARS-CoV-2 testing strategies to contain school-associated transmission: model-based analysis of impact and cost of diagnostic testing, screening, and surveillance
AID  - 10.1101/2021.05.12.21257131
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.12.21257131
4099  - http://medrxiv.org/content/early/2021/08/10/2021.05.12.21257131.1.short
4100  - http://medrxiv.org/content/early/2021/08/10/2021.05.12.21257131.1.full
AB  - Background In March 2021, the Biden administration allocated $10 billion for COVID-19 testing in schools. We evaluate the costs and benefits of testing strategies to reduce the infection risks of full-time in-person K-8 education at different levels of community incidence.Methods We used an agent-based network model to simulate transmission in elementary and middle school communities, parameterized to a US school structure and assuming dominance of the delta COVID-19 variant. We assess the value of different strategies for testing students and faculty/staff, including expanded diagnostic testing (“test to stay” policies that take the place of isolation for symptomatic students or quarantine for exposed classrooms); screening (routinely testing asymptomatic individuals to identify infections and contain transmission); and surveillance (testing a random sample of students to signaling undetected transmission and trigger additional investigation or interventions).Main outcome measures We project 30-day cumulative incidence of SARS-CoV-2 infection; proportion of cases detected; proportion of planned and unplanned days out of school; and the cost of testing programs and of childcare costs associated with different strategies. For screening policies, we further estimate cost per SARS-CoV-2 infection averted in students and staff, and for surveillance, probability of correctly or falsely triggering an outbreak response at different incidence and attack rates.Results Accounting for programmatic and childcare costs, “test to stay” policies achieve similar model-projected transmission to quarantine policies, with reduced overall costs. Weekly universal screening prevents approximately 50% of in-school transmission, with a lower projected societal cost than hybrid or remote schooling. The cost per infection averted in students and staff by weekly screening is lower for older students and schools with higher mitigation and declines as community transmission rises. In settings where local student incidence is unknown or rapidly changing, surveillance may trigger detection of moderate-to-large in-school outbreaks with fewer resources compared to screening.Conclusions “Test to stay” policies and/or screening tests can facilitate consistent in-person school attendance with low transmission risk across a range of community incidence. Surveillance may be a useful reduced-cost option for detecting outbreaks and identifying school environments that may benefit from increased mitigation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors were supported by the Centers for Disease Control and Prevention though the Council of State and Territorial Epidemiologists (NU38OT000297-02; AB, JAS), the National Institute of Allergy and Infectious Diseases (R37AI058736-16S1; AC, K01AI141576; MCF, and K08127908; EAK), the National Institute on Drug Abuse (3R37DA01561217S1; JAS), and Facebook (unrestricted gift; JG, AB, JAS). The papers' contents are solely the responsibility of the authors and do not represent the official views of the funders.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A -- simulation modelAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesModel code and replication files are publicly available as an R package on GitHub. https://github.com/abilinski/BackToSchool2